Inﬂammation might be an important factor in the progression from reﬂux to esophageal cancer, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association.
"Our research shows that damage to the esophageal lining that can be seen with endoscopy is important in the progression from normal cells to cancer, and Barrett's esophagus is likely to be an intermediate step," said Rune Erichsen, MD, of Aarhus University Hospital and lead author of this study.
In the past three decades, the incidence of esophageal cancer has increased dramatically in the U.S. and Europe. It is estimated that as many as 10,000 new cases will be diagnosed each year in the U.S. In addition, the risk of death associated with the disease is substantial.
Gastroesophageal reﬂux disease (GERD) is a key risk factor for esophageal cancer. The speciﬁc role of inﬂammation of the lining of the esophagus from GERD - clinically known as erosive reﬂux disease - is less clear.
"Although reﬂux patients with a history of inflammation, irritation or swelling of the esophagus are at increased risk for esophageal cancer, the absolute risk of cancer even in these patients is very low," added Dr. Erichsen.
Using data from population-based Danish medical registries (1996 through 2008) of 33,849 patients with reﬂux disease, a team of researchers performed a nationwide cohort study. They found that 26,194 of the patients (77 percent) had erosive reﬂux disease and 37 subsequently developed esophageal cancer after a mean follow-up time of 7.4 years. The incidence of cancer among patients with erosive reﬂux disease was signiﬁcantly greater than that expected for the general population. However, of the 7,655 patients with nonerosive reﬂux disease, only one was diagnosed with esophageal cancer after 4.5 years of follow-up.